Touch Bionics
Financials
Estimates*
EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|---|
Revenues | 18.1m | 10.0m | 11.0m | 17.9m | 20.1m | 12.9m | 15.8m |
% growth | 11 % | (44 %) | 9 % | 63 % | 12 % | (36 %) | 23 % |
EBITDA | 1.1m | 2.4m | 1.5m | 4.1m | 6.9m | 1.5m | 4.6m |
% EBITDA margin | 6 % | 24 % | 13 % | 23 % | 35 % | 12 % | 29 % |
Profit | <1m | 10.6m | 2.2m | 3.2m | 5.2m | <1m | 3.3m |
% profit margin | - | 105 % | 20 % | 18 % | 26 % | 6 % | 21 % |
R&D budget | - | <1m | 2.2m | 2.1m | - | - | - |
R&D % of revenue | - | 8 % | 20 % | 12 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Early VC | ||
£800k | Grant | ||
N/A | £2.5m | Debt | |
£2.5m | Early VC | ||
N/A | £27.5m Valuation: £27.5m 1.8x EV/LTM Revenues 30.1x EV/LTM EBITDA | Acquisition | |
Total Funding | €4.0m |
Related Content
Recent News about Touch Bionics
EditTouch Bionics specializes in advanced prosthetic solutions designed to enhance the mobility and quality of life for individuals with upper limb loss or differences. The company operates in the healthcare and medical devices market, serving patients, healthcare providers, and rehabilitation centers. Touch Bionics offers a range of products tailored to different activity levels, including high-performance prostheses for active users and balance solutions for less active individuals. Their business model focuses on direct sales to healthcare institutions and partnerships with medical professionals. Revenue is generated through the sale of prosthetic devices, post-operative solutions, and educational resources for professionals. The company also provides training and certification opportunities through its Academy, ensuring that healthcare providers are well-equipped to use their products.
Keywords: prosthetics, upper limb loss, mobility, healthcare, medical devices, rehabilitation, post-operative, training, certification, balance solutions.